PHVS · Pharvaris N.V. · Metrics
Market Cap
$2.24B
Shares
70.79M
Volume · Nov 20
218.81K
Avg daily vol (3M)
755.25K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
PHVS metrics
51 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$31.66
Market cap
$2.24B
Price action
23 metricsPrice change (1W)
-6.4%
Price change (30D)
+3.3%
Price change (3M)
-13.0%
Price change (6M)
+3.7%
Price change (YTD)
+14.1%
Price change (1Y)
+29.0%
Trailing year
Price change (5Y)
+103.3%
52-week high
$38.86
52-week low
$23.68
Change from 52-week high
-18.5%
Change from 52-week low
+33.7%
Annualized volatility
52.5%
Annualized volatility (3M)
41.2%
Implied volatility (30D)
74.7%
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
0.8
RSI (14D)
42.8
Price vs SMA 50
-3.6%
Price vs SMA 200
+0.7%
Avg volume (3M)
755,253
Relative volume
0.4
Average dollar volume
$26.02M
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
70.79M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
6.5
reciprocal yield 15.3%
FCF yield
-8.1%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$168.56M
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+19.9%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
—
Debt / equity
—
Current ratio
—
EBITDA (TTM)
—
Free cash flow (TTM)
−$181.14M
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$363.38M
Total assets
$375.24M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$181.03M
Capital expenditures (TTM)
$115,781
R&D (TTM)
$150.61M
SG&A (TTM)
—
Stock compensation (TTM)
$24.44M
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
135
13F filer change QoQ
+10
Institutional ownership
94.9%
Conviction holders (share of 13F filers)
11.1%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+3.4%
Holder tenure
12.6
Price vs estimated holder cost
+19.4%
Ownership (registered funds)
1 metricsIndex-fund ownership
0.4%
Short interest
3 metricsShort interest
3.6%
Latest settlement · 3.6 days to cover
Days to cover
3.6d
Short-squeeze score
53 / 100
Insider activity
2 metricsNet insider buying (90D)
−$20.34M
Insider-sentiment score
3 / 100
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1830487
CUSIP
N69605108
13F (30d)
150 filings
134 filers
Visit website
Investor relations